Anal Margin Squamous Cell Carcinoma: Clinical Trials

2 trials for Anal Margin Squamous Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 2

Follow Anal Margin Squamous Cell Carcinoma: new trials by email Literature Review of Anal Margin Squamous Cell Carcinoma trials Research Report on Anal Margin Squamous Cell Carcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Anoscopy, Biospecimen Collection, Capecitabine - AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)402022-08-092026-11-12
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
Biopsy, Biospecimen Collection, Capecitabine - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma
Phase 2Active not recruitingECOG-ACRIN Cancer Research Group2522020-01-022026-10-19

Narrower conditions

Anus Neoplasms (2)  ·  Anal Canal Carcinoma (1)  ·  HIV Infections (1)  ·  Rectal Neoplasms (1)

Broader conditions

Anus Diseases (2)  ·  Colorectal Neoplasms (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Intestinal Diseases (2)  ·  Intestinal Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Rectal Diseases (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)

Interventions

Capecitabine (2)  ·  Fluorodeoxyglucose F18 (2)  ·  Fluorouracil (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Mitomycin (2)  ·  Mitozytrex (2)  ·  Radiotherapy, Intensity-Modulated (2)  ·  Specimen Handling (2)  ·  dehydroftorafur (2)  ·  Biopsy (1)  ·  Colonoscopy (1)  ·  Nivolumab (1)  ·  Proctoscopy (1)  ·  Sentinel Lymph Node Biopsy (1)  ·  Sigmoidoscopy (1)

Sponsors

ECOG-ACRIN Cancer Research Group (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)

Top investigators

Jennifer A Dorth (1)  ·  Rafi Kabarriti (1)

NIH funding

U10CA180820 (1), UM1CA121947 (1)